Literature DB >> 31268966

Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.

Sara Capiau1, Herman Veenhof2, Remco A Koster2,3, Yngve Bergqvist4, Michael Boettcher5, Otto Halmingh6, Brian G Keevil7, Birgit C P Koch8, Rafael Linden9, Constantinos Pistos10, Leo M Stolk11, Daan J Touw2,12, Christophe P Stove1, Jan-Willem C Alffenaar2,13,14.   

Abstract

Dried blood spot (DBS) analysis has been introduced more and more into clinical practice to facilitate Therapeutic Drug Monitoring (TDM). To assure the quality of bioanalytical methods, the design, development and validation needs to fit the intended use. Current validation requirements, described in guidelines for traditional matrices (blood, plasma, serum), do not cover all necessary aspects of method development, analytical- and clinical validation of DBS assays for TDM. Therefore, this guideline provides parameters required for the validation of quantitative determination of small molecule drugs in DBS using chromatographic methods, and to provide advice on how these can be assessed. In addition, guidance is given on the application of validated methods in a routine context. First, considerations for the method development stage are described covering sample collection procedure, type of filter paper and punch size, sample volume, drying and storage, internal standard incorporation, type of blood used, sample preparation and prevalidation. Second, common parameters regarding analytical validation are described in context of DBS analysis with the addition of DBS-specific parameters, such as volume-, volcano- and hematocrit effects. Third, clinical validation studies are described, including number of clinical samples and patients, comparison of DBS with venous blood, statistical methods and interpretation, spot quality, sampling procedure, duplicates, outliers, automated analysis methods and quality control programs. Lastly, cross-validation is discussed, covering changes made to existing sampling- and analysis methods. This guideline of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology on the development, validation and evaluation of DBS-based methods for the purpose of TDM aims to contribute to high-quality micro sampling methods used in clinical practice.

Entities:  

Mesh:

Year:  2019        PMID: 31268966     DOI: 10.1097/FTD.0000000000000643

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  31 in total

1.  A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study.

Authors:  Ganesh S Moorthy; Kevin J Downes; Christina Vedar; Athena F Zuppa
Journal:  Bioanalysis       Date:  2020-09-18       Impact factor: 2.681

2.  Direct Derivatization in Dried Blood Spots for Oxidized and Reduced Glutathione Quantification in Newborns.

Authors:  Isabel Ten-Doménech; Álvaro Solaz-García; Inmaculada Lara-Cantón; Alejandro Pinilla-Gonzalez; Anna Parra-Llorca; Máximo Vento; Guillermo Quintás; Julia Kuligowski
Journal:  Antioxidants (Basel)       Date:  2022-06-14

3.  Development and validation of a volumetric absorptive microsampling- liquid chromatography mass spectrometry method for the analysis of cefepime in human whole blood: Application to pediatric pharmacokinetic study.

Authors:  Ganesh S Moorthy; Christina Vedar; Nicole R Zane; Kevin J Downes; Janice L Prodell; Mary Ann DiLiberto; Athena F Zuppa
Journal:  J Pharm Biomed Anal       Date:  2019-11-20       Impact factor: 3.935

4.  Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA).

Authors:  Andre Knoop; Hans Geyer; Oliver Lerch; Ana Rubio; Yvonne Schrader; Mario Thevis
Journal:  Anal Sci Adv       Date:  2021-03-26

5.  Development and Validation of a Dried Blood Spot Assay Using UHPLC-MS/MS to Identify and Quantify 12 Antihypertensive Drugs and 4 Active Metabolites: Clinical Needs and Analytical Limitations.

Authors:  Laura E J Peeters; Soma Bahmany; Tim Dekker; Aya Aliawi; Bart van Domburg; Jorie Versmissen; Birgit C P Koch
Journal:  Ther Drug Monit       Date:  2022-04-05       Impact factor: 3.118

Review 6.  Microsampling Assays for Pharmacokinetic Analysis and Therapeutic Drug Monitoring of Antimicrobial Drugs in Children: A Critical Review.

Authors:  Ganesh S Moorthy; Christina Vedar; Kevin J Downes; Julie C Fitzgerald; Marc H Scheetz; Athena F Zuppa
Journal:  Ther Drug Monit       Date:  2021-06-01       Impact factor: 3.118

7.  Volumetric Absorptive Microsampling as an Alternative Tool for Biomonitoring of Multi-Mycotoxin Exposure in Resource-Limited Areas.

Authors:  Arnau Vidal; Lidia Belova; Christophe Stove; Marthe De Boevre; Sarah De Saeger
Journal:  Toxins (Basel)       Date:  2021-05-11       Impact factor: 4.546

8.  Development and Validation of a Simple and Sensitive LC-MS/MS Method for Quantification of Metformin in Dried Blood Spot Its Application as an Indicator for Medication Adherence.

Authors:  Bushra T ALquadeib; Nouf M Aloudah; Alanood S Almurshedi; Iman M ALfagih; Basmah N ALdosari; Adim S ALmeleky; Nour M Almubyedh
Journal:  Int J Gen Med       Date:  2021-07-08

Review 9.  Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm.

Authors:  Marissa F Dockendorf; Bryan J Hansen; Kevin P Bateman; Matthew Moyer; Jyoti K Shah; Lisa A Shipley
Journal:  Clin Transl Sci       Date:  2020-11-30       Impact factor: 4.689

10.  Analysis of tamoxifen and its metabolites in dried blood spot and volumetric absorptive microsampling: comparison and clinical application.

Authors:  Baitha Palanggatan Maggadani; Yahdiana Harahap; Samuel J Haryono; Christoffel William Putra Untu
Journal:  Heliyon       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.